PDCD1 and neoplasm: Interestingly, recent studies have demonstrated that dual inhibitors, combining anti-PD1/PD-L1 antibodies with cytotoxic agents such as tubulin inhibitors, accomplish synergistic effects and show better anti-tumor efficacy than chemotherapy alone [34].